# A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan

> **NCT05442645** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 80 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05442645
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-20
- **Primary completion:** 2023-06-27
- **Final completion:** 2024-06-18
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05442645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05442645, "A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05442645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*